# China Shineway Pharmaceutical Group Limited (CSWYF)

> Healthcare · CN · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CSWYF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | N/A | N/A | N/A | $ 334.90M | $ 8.06B |
| 2024 | $ 5.86B | $ 1.45B | $ 1.31B | $ 346.53M | $ 7.47B |
| 2023 | $ 68.84B | $ 530.98M | $ 425.93M | $ 303.29M | $ 6.62B |
| 2022 | $ 4.44B | $ 811.89M | $ 1.16B | $ 7.44M | $ 6.29B |
| 2021 | $ 3.81B | $ 657.78M | $ 811.70M | $ 14.89M | $ 5.89B |
| 2020 | $ 3.32B | $ 375.45M | $ 789.08M | $ 391.28M | $ 5.78B |
| 2019 | $ 3.50B | $ 651.24M | $ 450.11M | $ 400.21M | $ 5.72B |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.04 |
| Liabilities / Eq | 0.34 |
| Current Ratio | 3.71 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 0.45 |
| Gross Debt / FCF | 0.41 |

## Other views

- [Metrics](https://sponda.capital/en/CSWYF.md)
- [Charts](https://sponda.capital/en/CSWYF/charts.md)
- [Compare](https://sponda.capital/en/CSWYF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.